Background: Suspension therapy was developed by a Russian doctor, A. Motschutkovsky and at the end of the 19th century it was a popular treatment for tabes dorsalis. It was endorsed by Jean-Martin Charcot in France and Weir Mitchell in the United States; but after 10 years, it was abandoned because it proved to be useless and some patients developed paralysis. Summary: The effect of suspension upon a spinal cord affected by tabes dorsalis and a healthy spinal cord has been analyzed in the light of current knowledge. The benefits of suspension were thought to be due to an improvement in the blood supply to the spinal cord and due to the suggestibility or the placebo effect. Key Message: Analysis of the contemporary literature in the light of current research shows that suspension therapy was a powerful weapon that could cause impairment to the conductivity of the spinal cord and this has important implications for current therapy such as the use of Harrington rods.

1.
Vein A: Jean-Martin Charcot at the birth of Russian neurology. Eur Neurol 2011;65:75-81.
2.
Lanska DJ, Edmonson JM: The suspension therapy for Tabes Dorsalis: a case history of a therapeutic fad. Arch Neurol 1990;47:701-704.
3.
Goetz G, Bonduelle M, Gelfland T: Charcot: Constructing Neurology. Oxford, Oxford University Press, 1995, pp 159-161.
4.
Bogousslavsky J: Following Charcot: A Forgotten History of Neurology and Psychiatry. Karger, Basel, Switzerland, 2011.
5.
Ohry A: Spinal therapeutics before our times. Prog Health Sci 2011;1:196-199.
6.
Weiner M-F, Silver JR: Spinal institutions in post-revolutionary France. Spinal Cord 2010;48:274-284.
7.
Weiner M-F, Silver JR: Paralysis as a result of traction for the treatment of scoliosis: a forgotten lesson from history. Spinal Cord 2009;47:429-434.
8.
Sayre L: Spinal Disease and Spinal Curvature, their Treatment by Suspension and the Use of the Plaster of Paris Bandage. London, Smith Elder & Co, 1877, p 121.
9.
Motschutkovsky A: The treatment of certain diseases of the spinal cord by means of suspension (translated from the Russian by De Watteville A); in Brain: A Journal of Neurology. London and New York, Macmillan and Co, 1889-1990, vol XII, pp 327-345.
10.
Charcot JM: Du Traitement de l'Ataxie Locomotrice par la Suspension suivant la Méthode du Dr Motchoutkowsky. Leçons du Mardi à la Salpétriêre. Leçon du 15 Janvier 1889. Progrès Médical. Paris, Lecrosnier & Babe, 1889, p 579.
11.
Russell JSR, Taylor J: Treatment by suspension; in De Watteville A (ed): Brain: A Journal of Neurology. London and New York, Macmillan and Co, 1890, vol XIII, pp 207-223.
12.
De la Tourette G: Modifications Apportées à la Technique de la Suspension dans le Traitement de l'Ataxie Locomotrice et de quelques autres Maladies du Système Nerveux. Le Progrès Médical 1890;18(2ème série)XI:457-459.
13.
Haushalter P, Adam A: De la suspension dans le traitement sur des malades du système nerveux. Le Progrès Médical 1889;17(2ème série)X:493-494.
14.
De la Tourette G: Leçons de Clinique Thérapeutique sur les Maladies du Système Nerveux. Paris, Librairie Plon 1898, pp 460-475.
15.
Oppenheim H: Textbook of Nervous Diseases for Physicians and Students vol II (translated by Alex Bruce). Edinburgh, Otto Schulze and Company, vol 191, pp 144, 173.
16.
Weir Mitchell S: Suspension in locomotor ataxia. University Medical Magazine, April 1890, pp 1-5.
17.
Philippon J, Poirier J: Joseph Babinsky. Oxford, Oxford University Press, 2009, pp 283, 343.
18.
Bramwell B: Diseases of the Spinal Cord. Edinburgh, Young J Pentland, 1884, p 356.
19.
Maupassant de G: Le Horla. Paris, Paul Ollendorff, 1887.
20.
Daudet A: La Doulou (published posthumously in 1931 by Léon Daudet and translated by Julian Barnes); in The Land of Pain. London, Cape J, 2002.
21.
Vora SK, Lyons RW: The medical Kipling Syphilis, Tabes Dorsalis, and Romberg's Test. Emerg Infect Dis 2006;10:1160-1162.
22.
Clifford Rose F, Bynum WF: Historical Aspects of the Neurosciences: A Festschrift for Macdonald Critchley. New York, Raven Press, 1982, p 402.
23.
Reports on Society Royal Medical and Chirurgical Society: British Medical Journal 1890, p 131.
24.
Reports on Society Royal Medical and Chirurgical Society: British Medical Journal 1890, p 238.
25.
Silver JR: Paraplegia as a result of tracheal resection in a 17 year-old male. Spinal Cord 2007;45:576-578.
26.
Cyriax J: Treatment by manipulation and massage; in Textbook of Orthopaedic Medicine vol II. London, Cassell, 1965, pp 104-106.
27.
Wilkinson M: Cervical Spondylosis: Its Early Diagnosis and Treatment. London, William Heinemann Medical Books Ltd, 1971.
28.
Symonds C: The interrelation of trauma and cervical spondylosis in compression of the cervical cord. The Lancet 1953;1:451-454.
29.
Wilkinson M: The anatomy and pathology of cervical spondylosis. Proc R Soc Med 1964;57:159-162.
30.
Keane FX: Pain and cervical traction variation during manual turning. Paraplegia 1978;15:343-348.
31.
Brieg A: Skull Traction and Cervical Cord Injury: A New Approach to Improved Rehabilitation. Berlin, Heidelberg, Springer-Verlag, 1989, pp 14-15.
32.
Takahashi K, et al: Influence of intramedullar stress on cervical spondylotic myelophathy. Spinal Cord 2013;51:761-764.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.